VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--June 21, 2006--Gentium S.p.A. (NASDAQ:GENT - News; the Company) today announced that the Company's lead product, Defibrotide, will be the subject of a symposium, "An Update on Defibrotide as an Anti-thrombotic and Anti-ischemic Drug," on June 26, 2006 from 4:30 p.m. - 6:00 p.m. at the XXII World Congress of the International Union of Angiology taking place in Lisbon, Portugal from June 24-26, 2006 at the Lisboa Conference Centre.
